231 related articles for article (PubMed ID: 36362484)
1. Unmet Needs in TAVR: Conduction Disturbances and Management of Coronary Artery Disease.
Auffret V; Ridard C; Salerno N; Sorrentino S
J Clin Med; 2022 Oct; 11(21):. PubMed ID: 36362484
[TBL] [Abstract][Full Text] [Related]
2. The incidence and impact of cardiac conduction disturbances after transcatheter aortic valve replacement.
Chen S; Chau KH; Nazif TM
Ann Cardiothorac Surg; 2020 Nov; 9(6):452-467. PubMed ID: 33312903
[TBL] [Abstract][Full Text] [Related]
3. Frequency of conduction disturbances after Edwards SAPIEN percutaneous valve implantation.
Laynez A; Ben-Dor I; Barbash IM; Hauville C; Sardi G; Maluenda G; Xue Z; Satler LF; Pichard AD; Lindsay J; Waksman R
Am J Cardiol; 2012 Oct; 110(8):1164-8. PubMed ID: 22770935
[TBL] [Abstract][Full Text] [Related]
4. Electrophysiologic Implications of Transcatheter Aortic Valve Replacement: Incidence, Outcomes, and Current Management Strategies.
Barrett C; Sandhu A; Tzou W
Curr Cardiol Rep; 2021 Oct; 23(11):167. PubMed ID: 34599417
[TBL] [Abstract][Full Text] [Related]
5. Management of Coronary Artery Disease and Conduction Abnormalities in Transcatheter Aortic Valve Implantation.
Kostopoulou A; Karyofillis P; Livanis E; Karavolias G; Theodorakis G; Paraskevaides J; Voudris V
Curr Treat Options Cardiovasc Med; 2016 Feb; 18(2):9. PubMed ID: 26781657
[TBL] [Abstract][Full Text] [Related]
6. Conduction Disturbances After Transcatheter Aortic Valve Replacement: Current Status and Future Perspectives.
Auffret V; Puri R; Urena M; Chamandi C; Rodriguez-Gabella T; Philippon F; Rodés-Cabau J
Circulation; 2017 Sep; 136(11):1049-1069. PubMed ID: 28893961
[TBL] [Abstract][Full Text] [Related]
7. [Transcatheter aortic valve implantation and conduction disturbances].
Ait Said M; Coquard C; Horvilleur J; Manenti V; Fiorina L; Lacotte J; Salerno F
Ann Cardiol Angeiol (Paris); 2019 Dec; 68(6):443-449. PubMed ID: 31668339
[TBL] [Abstract][Full Text] [Related]
8. Incidence, Predictors, and Implications of Permanent Pacemaker Requirement After Transcatheter Aortic Valve Replacement.
Sammour Y; Krishnaswamy A; Kumar A; Puri R; Tarakji KG; Bazarbashi N; Harb S; Griffin B; Svensson L; Wazni O; Kapadia SR
JACC Cardiovasc Interv; 2021 Jan; 14(2):115-134. PubMed ID: 33478630
[TBL] [Abstract][Full Text] [Related]
9. Conduction Abnormalities and Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement Using the Repositionable LOTUS Device: The United Kingdom Experience.
Rampat R; Khawaja MZ; Hilling-Smith R; Byrne J; MacCarthy P; Blackman DJ; Krishnamurthy A; Gunarathne A; Kovac J; Banning A; Kharbanda R; Firoozi S; Brecker S; Redwood S; Bapat V; Mullen M; Aggarwal S; Manoharan G; Spence MS; Khogali S; Dooley M; Cockburn J; de Belder A; Trivedi U; Hildick-Smith D
JACC Cardiovasc Interv; 2017 Jun; 10(12):1247-1253. PubMed ID: 28641846
[TBL] [Abstract][Full Text] [Related]
10. Overcoming the transcatheter aortic valve replacement Achilles heel: conduction abnormalities-a systematic review.
Alperi A; Muntané-Carol G; Freitas-Ferraz AB; Junquera L; Del Val D; Faroux L; Philippon F; Rodés-Cabau J
Ann Cardiothorac Surg; 2020 Nov; 9(6):429-441. PubMed ID: 33312901
[TBL] [Abstract][Full Text] [Related]
11. Predictors of right ventricular pacing and pacemaker dependence in transcatheter aortic valve replacement patients.
Sharma E; Chu AF
J Interv Card Electrophysiol; 2018 Jan; 51(1):77-86. PubMed ID: 29260369
[TBL] [Abstract][Full Text] [Related]
12. Conduction Disturbances and Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement: Predictors and Prevention.
Tsoi M; Tandon K; Zimetbaum PJ; Frishman WH
Cardiol Rev; 2022 Jul-Aug 01; 30(4):179-187. PubMed ID: 34132653
[TBL] [Abstract][Full Text] [Related]
13. Low permanent pacemaker rates following Lotus device implantation for transcatheter aortic valve replacement due to modified implantation protocol.
Krackhardt F; Kherad B; Krisper M; Pieske B; Laule M; Tschöpe C
Cardiol J; 2017; 24(3):250-258. PubMed ID: 28248410
[TBL] [Abstract][Full Text] [Related]
14. A Disruptive Technology: Determining Need for Permanent Pacing After TAVR.
Sandhu A; Tzou WS
Curr Cardiol Rep; 2021 Apr; 23(5):53. PubMed ID: 33871728
[TBL] [Abstract][Full Text] [Related]
15. Can we reduce conduction disturbances following transcatheter aortic valve replacement?
Alperi Garcia A; Muntané-Carol G; Junquera L; Del Val D; Faroux L; Philippon F; Rodés-Cabau J
Expert Rev Med Devices; 2020 Apr; 17(4):309-322. PubMed ID: 32162571
[No Abstract] [Full Text] [Related]
16. Preprocedural and procedural variables that predict new-onset conduction disturbances after transcatheter aortic valve replacement.
Boonyakiatwattana W; Maneesai A; Chaithiraphan V; Jakrapanichakul D; Sakiyalak P; Chunhamaneewat N; Slisatkorn W; Chotinaiwattarakul C; Pongakasira R; Wongpraparut N
BMC Cardiovasc Disord; 2022 Mar; 22(1):135. PubMed ID: 35361124
[TBL] [Abstract][Full Text] [Related]
17. Clinical implications of new-onset left bundle branch block after transcatheter aortic valve replacement: analysis of the PARTNER experience.
Nazif TM; Williams MR; Hahn RT; Kapadia S; Babaliaros V; Rodés-Cabau J; Szeto WY; Jilaihawi H; Fearon WF; Dvir D; Dewey TM; Makkar RR; Xu K; Dizon JM; Smith CR; Leon MB; Kodali SK
Eur Heart J; 2014 Jun; 35(24):1599-607. PubMed ID: 24179072
[TBL] [Abstract][Full Text] [Related]
18. Predictors of conduction recovery after permanent pacemaker implantation following transcatheter aortic valve replacement.
Phan DQ; Goitia J; Lee MS; Gupta N; Aharonian V; Mansukhani P; Moore N; Brar SS; Zadegan R
J Interv Card Electrophysiol; 2021 Aug; 61(2):365-374. PubMed ID: 32671716
[TBL] [Abstract][Full Text] [Related]
19. Perioperative conduction disturbances after transcatheter aortic valve replacement.
Ghadimi K; Patel PA; Gutsche JT; Sophocles A; Anwaruddin S; Szeto WY; Augoustides JG
J Cardiothorac Vasc Anesth; 2013 Dec; 27(6):1414-20. PubMed ID: 24103715
[TBL] [Abstract][Full Text] [Related]
20. New-onset left bundle branch block after transcatheter aortic valve replacement is associated with adverse long-term clinical outcomes in intermediate-risk patients: an analysis from the PARTNER II trial.
Nazif TM; Chen S; George I; Dizon JM; Hahn RT; Crowley A; Alu MC; Babaliaros V; Thourani VH; Herrmann HC; Smalling RW; Brown DL; Mack MJ; Kapadia S; Makkar R; Webb JG; Leon MB; Kodali SK
Eur Heart J; 2019 Jul; 40(27):2218-2227. PubMed ID: 31505615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
